Skip to main content
Fig. 4 | Alzheimer's Research & Therapy

Fig. 4

From: Model-based stratification of progression along the Alzheimer disease continuum highlights the centrality of biomarker synergies

Fig. 4

Differences in the role of CSF Aβ and CSF p-tau in progression along the AD continuum. A Contingency table showing significant difference in the ratio of tau positivity between the two progression phenotypes. B CSF Aβ differences in cognitive progression phenotypes predicted by a PENet model using T(N) biomarkers only. C CSF p-tau differences in cognitive progression phenotypes predicted by the PENet model using A(N) biomarkers only. *Significant differences (p < 0.05)

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193